SCHEMBL7718074

SCHEMBL7718074

CCCOc1ccccc1C(=O)Nc1ncccc1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
HPGD P15428 1/20 0.55
HSD17B10 Q99714 1/20 0.55
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
NR1I2 O75469 1/20 0.53
LMNA P02545 1/20 0.53
CHRM2 P08172 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADRA2A P08913 1/20 0.53
MAPT P10636 1/20 0.53
OPRK1 P41145 1/20 0.53
HTR2B P41595 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
TP53 P04637 1/20 0.51
HTT P42858 2/20 0.49
HIF1A Q16665 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7721826 0.84 PTPN1 (0.58) BRD4ALDH1A1KMT2AMEN1NR1I2
SCHEMBL7163100 0.82 MAPT (0.58) BRD4ALDH1A1HSD17B10KMT2AMEN1
SCHEMBL7721484 0.80 RXFP1 (0.56) BRD4KMT2AMEN1NR1I2LMNA
SCHEMBL7726031 0.80 RXFP1 (0.53) BRD4ALDH1A1KMT2AMEN1NR1I2
SCHEMBL3352936 0.80 LMNA (0.79) KDM4EALDH1A1KMT2AMEN1NR1I2
Hydrochloric Acid SCHEMBL1239153 0.78 LMNA (0.77) KDM4EALDH1A1KMT2AMEN1NR1I2
Hydrochloric Acid SCHEMBL7831044 0.78 LMNA (0.77) KDM4EALDH1A1KMT2AMEN1NR1I2
SCHEMBL7167278 0.78 MAPT (0.53) BRD4ALDH1A1KMT2AMEN1NR1I2
SCHEMBL15528360 0.78 HTT (0.60) ALDH1A1HPGDKMT2AMEN1LMNA
SCHEMBL7960802 0.77 MEN1 (0.64) KDM4EALDH1A1HPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391885-B1 CONTROLLING APOPTOSIS IN AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2002-05-21 US disclosed
US-6060477-A Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives CELL PATHWAYS, INC. (US) 2000-05-09 US disclosed
EP-0347146-B1 FUSED PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-09-01 EP disclosed
US-5047404-A Fused pyrimidine derivatives bronchodilator agents, antiallergens SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-09-10 US disclosed
EP-0347146-A2 Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP disclosed